Constipation severity was significantly lower in the neomycin and rifaximin group ( @ ) compared to neomycin alone ( @ ) ( P = @ ) , with greater improvement in constipation ( P = @ ) , straining ( P = @ ) and bloating ( P = @ ) , but not abdominal pain .